{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:01Z","timestamp":1786119061789,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/ftd.0b013e31816b9063","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T19:42:50Z","timestamp":1236109370000},"page":"151-158","source":"Crossref","is-referenced-by-count":40,"title":["Toxicodynamic Therapeutic Drug Monitoring of Immunosuppressants: Promises, Reality, and Challenges"],"prefix":"10.1097","volume":"30","author":[{"given":"Uwe","family":"Christians","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel","family":"Sch\u00f6ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Bendrick-Peart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Klawitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Haschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost","family":"Klawitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1359-6446(05)03440-9","article-title":"Combinatorial biomarkers: from early toxicology assays to patient population profiling.","volume":"10","author":"Koop","year":"2005","journal-title":"Drug Discov Today"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tibtech.2004.06.005","article-title":"Biomarker discovery and validation: technologies and integrative approaches.","volume":"22","author":"Ilyin","year":"2004","journal-title":"Trends Biotechnol"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/j.ackd.2005.11.004","article-title":"Chronic allograft dysfunction.","volume":"13","author":"Baluja","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1681\/ASN.2005030285","article-title":"American Society of Nephrology Renal Research Report.","volume":"16","author":"Berl","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R6-4-20210129","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996.","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in allograft survival despite a marked decrease in acute rejection rates over the most recent era.","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"R10-4-20210129","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1681\/ASN.2005050463","article-title":"Chronic renal allograft dysfunction.","volume":"16","author":"Chapman","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 11","key":"R11-4-20210129","first-page":"SS42","article-title":"Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.","volume":"71","author":"Campistol","year":"2001","journal-title":"Transplantation"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000225783.86950.c2","article-title":"Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants.","volume":"82","author":"Kee","year":"2006","journal-title":"Transplantation"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2165\/00003495-200565050-00004","article-title":"Combating chronic renal allograft dysfunction. Optimal immunosuppressive regimens.","volume":"65","author":"Merville","year":"2005","journal-title":"Drugs"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1399-0012.2005.00303.x","article-title":"Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction.","volume":"19","author":"Miyagi","year":"2005","journal-title":"Clin Transplant"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.mot.0000184018.31573.34","article-title":"Biomarkers of immunosuppressive drug toxicity.","volume":"10","author":"Christians","year":"2005","journal-title":"Curr Opin Organ Transplant"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.mot.0000184016.85831.dc","article-title":"Novel biomarkers of allograft rejection: omics approaches start to deliver.","volume":"10","author":"Raulf","year":"2005","journal-title":"Curr Opin Organ Transplant"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.ftd.0000194500.40021.37","article-title":"Proteomic research in renal transplantation.","volume":"28","author":"Clarke","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.tp.0000268808.39401.e8","article-title":"Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology.","volume":"84","author":"Schaub","year":"2007","journal-title":"Transplantation"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1074\/mcp.M300127-MCP200","article-title":"The human plasma proteome: a nonredundant list developed by combination of four separate sources.","volume":"3","author":"Anderson","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"R20-4-20210129","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"Metabolomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"R21-4-20210129","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cbpa.2003.08.008","article-title":"Metabolomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterization of xenobiotics toxicity and disease diagnostic.","volume":"7","author":"Griffin","year":"2003","journal-title":"Curr Opin Chem Biol"},{"key":"R22-4-20210129","first-page":"127","article-title":"High-resolution NMR for metabolomics.","volume":"8","author":"Pelczer","year":"2005","journal-title":"Curr Opin Drug Discov Dev"},{"key":"R23-4-20210129","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1039\/b418288j","article-title":"Measuring the metabolome: current analytical technologies.","volume":"130","author":"Dunn","year":"2005","journal-title":"Analyst"},{"key":"R24-4-20210129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd728","article-title":"Metabolomics: a platform for studying drug toxicity and gene function.","volume":"1","author":"Nicholson","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"R25-4-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1568026023394498","article-title":"Metabolomic applications in toxicity screening and disease diagnosis.","volume":"2","author":"Shockcor","year":"2002","journal-title":"Curr Top Med Chem"},{"key":"R26-4-20210129","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1600-6143.2004.00526.x","article-title":"Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes.","volume":"4","author":"Flechner","year":"2004","journal-title":"Am J Transplant"},{"key":"R27-4-20210129","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1600-6143.2007.01797.x","article-title":"Early loss of renal transcripts in kidney allografts: relationship to the development of histologic lesions and alloimmune effector mechanisms.","volume":"7","author":"Einecke","year":"2007","journal-title":"Am J Transplant"},{"key":"R28-4-20210129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncpneph0066","article-title":"Microarrays and transcriptome analysis in renal transplantation.","volume":"2","author":"Halloran","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"R29-4-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/clinchem.2006.078972","article-title":"Quantification of 15-F2t-isoprostane in human urine and plasma using high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.","volume":"53","author":"Haschke","year":"2007","journal-title":"Clin Chem"},{"key":"R30-4-20210129","first-page":"F172","article-title":"A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin.","volume":"276","author":"Lorenz","year":"1999","journal-title":"Am J Physiol"},{"key":"R31-4-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-364930-0.50007-5","article-title":"Cyclosporine nephrotoxicity.","volume":"30","author":"Racusen","year":"1988","journal-title":"Int Rev Exp Pathol"},{"key":"R32-4-20210129","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00007890-199402000-00001","article-title":"Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model.","volume":"57","author":"Andoh","year":"1994","journal-title":"Transplantation"},{"key":"R33-4-20210129","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/sj.bjp.0705939","article-title":"Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors.","volume":"143","author":"Christians","year":"2004","journal-title":"Br J Pharmacol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e31816b9063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:40:25Z","timestamp":1786038025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200804000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31816b9063","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}